Article
The methylenetetrahydrofolate reductase (MTHFR) 677 C>T polymorphism increases the risk of developing chronic myeloid leukemia-a case-control study.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Apr 2015
Bănescu Claudia, Iancu Mihaela, Trifa Adrian P, Macarie Ioan, Dima Delia, Dobreanu Minodora
Abstract excerpt
The methylenetetrahydrofolate reductase (MTHFR) 677 C>T and 1298 A>C polymorphisms are associated with variations in folate levels, a phenomenon linked to the development of various malignancies. The aim of this study was to investigate the influence of the 677 C>T and 1298 A>C polymorphisms in the MTHFR gene on the risk of developing chronic myeloid leukemia (CML). Our study included 151 patients with CML and...
Topics
- Adult
- Aged
- Alleles
- Female
- Genetic Association Studies
- Genetic Predisposition to Disease
- Humans
- Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
- Male
- Methylenetetrahydrofolate Reductase (NADPH2)
